APA (7th ed.) Citation

Guo, W., Li, B., Tang, L., Peng, L., & Guo, S. (2026). Reduced-dose anti-thymocyte globulin combined with post-transplant cyclophosphamide versus standard ATG for graft-versus-host disease prophylaxis in haploidentical hematopoietic stem cell transplantation: A focus on chronic GVHD reduction. Leukemia & Lymphoma, 67(6), 1385. https://doi.org/10.1080/10428194.2026.2645932

Chicago Style (17th ed.) Citation

Guo, Wenyi, Bo Li, Li Tang, Liang Peng, and Shuli Guo. "Reduced-dose Anti-thymocyte Globulin Combined with Post-transplant Cyclophosphamide Versus Standard ATG for Graft-versus-host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplantation: A Focus on Chronic GVHD Reduction." Leukemia & Lymphoma 67, no. 6 (2026): 1385. https://doi.org/10.1080/10428194.2026.2645932.

MLA (9th ed.) Citation

Guo, Wenyi, et al. "Reduced-dose Anti-thymocyte Globulin Combined with Post-transplant Cyclophosphamide Versus Standard ATG for Graft-versus-host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplantation: A Focus on Chronic GVHD Reduction." Leukemia & Lymphoma, vol. 67, no. 6, 2026, p. 1385, https://doi.org/10.1080/10428194.2026.2645932.